MedAvante-ProPhase Research Demonstrates Feasibility of Identifying “Atypical” patterns of CDR Domain Scoring

At 10th Clinical Trials on Alzheimer’s Disease (CTAD) MedAvante-ProPhase presented research and analysis addressing the need to identify administrations of the Clinical Dementia Rating scale (CDR) within clinical trials that have an increased probability of scoring errors to maintain data integrity and improve signal detection.

Continue reading